CDMO for injectable biologics and vaccines with FDA/EMA approval across 80+ countries
ROVI Pharma operates a large-scale contract manufacturing facility in Madrid serving pharma and biotech across injectables, biologics, and vaccines. The tech stack reflects pharma-grade operations: SAP for ERP, LIMS for lab data, SCADA/PLC for line control, and analytical instruments (HPLC, qPCR). Hiring remains tilted toward manufacturing and junior technical roles, with active projects centered on GMP compliance, process validation, and mechatronic system optimization—typical constraints for a regulated CDMO scaling capacity.
ROVI Pharma is a contract development and manufacturing organization (CDMO) headquartered in Madrid, Spain, with over 25 years of expertise in aseptic fill-finish operations. The company operates 12 injectable filling lines (prefilled syringes and vials) and secondary packaging systems for both injectables and solid forms, serving customers across more than 80 countries. ROVI is approved by major regulatory bodies including the FDA, EMA, ANVISA, PMDA, and KFDA. The product scope covers the full manufacturing chain: scale-up, compounding, aseptic filling, automatic inspection, labeling, blistering, packaging, serialization, and release testing. The organization has 1,001–5,000 employees and currently maintains active hiring across manufacturing, engineering, and quality functions.
Aseptic fill-finish for injectables (prefilled syringes and vials), with specialization in vaccines, monoclonal antibodies, mRNA, and oligonucleotide biologics. ROVI also handles solid-form packaging (tablets, sachets) and blistering.
Yes. ROVI holds approvals from FDA, EMA, ANVISA, PMDA, and KFDA, and manufactures for customers in more than 80 countries.
Primary systems include SAP (ERP), LIMS (lab data management), SCADA and PLC (line automation), HPLC and qPCR (analytical), and Microsoft Office. GCP listed for cloud infrastructure.
Other companies in the same industry, closest in size